Memantine
Dissociative, Tentative
An NMDA-antagonist that may produce a prolonged dissociative "hole" experience lasting up to 16+ hours. The drug is used clinically to slow the progression of moderate-to-severe Alzheimer's disease, among other uses=.
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Heavy
Oral
10-20mg
20-40mg
40-80mg+
Onset
Duration
After Effects
Oral
30m to 1h 30m
12 to 72
1 to 72
Memantine prevents aluminum-induced cognitive deficit in rats - https://www.ncbi.nlm.nih.gov/pubmed/21741993Classics in Chemical Neuroscience: Memantine - https://doi.org/10.1021/acschemneuro.7b00270